Janet Woodcock, director of the Center for Drug Evaluation and Research (Tom Williams/CQ Roll Call via AP Images)

CDER's Janet Wood­cock: Phar­ma, reg­u­la­tors have lessons to learn from Covid-19

When phar­ma­ceu­ti­cal com­pa­nies, health care lead­ers and reg­u­la­tors fi­nal­ly get a chance to de­brief and pull lessons learned from the coro­n­avirus pan­dem­ic, a chief take­away may re­volve around the many missed re­search op­por­tu­ni­ties. How­ev­er, learn­ings from Covid-19 may one day lead to nov­el tri­al de­sign and in­creased co­op­er­a­tion among these play­ers promise a bet­ter path for­ward when speed and safe­ty need equal con­sid­er­a­tion. This mes­sage was among many shared by a lead­ing reg­u­la­tor in a 9 No­vem­ber au­dio in­ter­view with ed­i­tors at the New Eng­land Jour­nal of Med­i­cine (NE­JM).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.